# Contribution of the Pharmacological Profile of the A2A Receptor to Adenosine in the Diagnosis of Myocardial Ischemia

> **NCT04640844** · NA · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 170 (estimated)

## Conditions studied

- Chronic Coronary Artery Disease

## Interventions

- **BIOLOGICAL:** blood sample

## Key facts

- **NCT ID:** NCT04640844
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-25
- **Primary completion:** 2022-12
- **Final completion:** 2023-06
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2021-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04640844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04640844, "Contribution of the Pharmacological Profile of the A2A Receptor to Adenosine in the Diagnosis of Myocardial Ischemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04640844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*